A detailed history of Keybank National Association transactions in Baxter International Inc stock. As of the latest transaction made, Keybank National Association holds 35,617 shares of BAX stock, worth $1.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,617
Previous 36,637 2.78%
Holding current value
$1.05 Million
Previous $1.23 Million 10.37%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$32.85 - $40.26 $33,507 - $41,065
-1,020 Reduced 2.78%
35,617 $1.35 Million
Q2 2024

Jul 31, 2024

BUY
$32.87 - $43.55 $4,108 - $5,443
125 Added 0.34%
36,637 $1.23 Million
Q1 2024

May 14, 2024

SELL
$37.88 - $43.77 $36,857 - $42,588
-973 Reduced 2.6%
36,512 $1.56 Million
Q4 2023

Feb 13, 2024

SELL
$31.71 - $38.95 $19,596 - $24,071
-618 Reduced 1.62%
37,485 $1.45 Million
Q3 2023

Nov 08, 2023

SELL
$37.32 - $49.29 $59,189 - $78,173
-1,586 Reduced 4.0%
38,103 $1.44 Million
Q2 2023

Aug 01, 2023

SELL
$39.98 - $47.68 $158,760 - $189,337
-3,971 Reduced 9.1%
39,689 $1.81 Million
Q1 2023

May 10, 2023

SELL
$37.58 - $52.57 $10,860 - $15,192
-289 Reduced 0.66%
43,660 $1.77 Million
Q4 2022

Jan 31, 2023

SELL
$49.7 - $57.71 $129,369 - $150,219
-2,603 Reduced 5.59%
43,949 $2.24 Million
Q3 2022

Oct 27, 2022

BUY
$53.86 - $66.8 $377 - $467
7 Added 0.02%
46,552 $2.51 Million
Q2 2022

Aug 08, 2022

SELL
$63.83 - $80.0 $148,149 - $185,680
-2,321 Reduced 4.75%
46,545 $2.99 Million
Q1 2022

Apr 28, 2022

SELL
$76.85 - $89.45 $111,125 - $129,344
-1,446 Reduced 2.87%
48,866 $3.79 Million
Q4 2021

Feb 07, 2022

BUY
$74.57 - $87.19 $47,873 - $55,975
642 Added 1.29%
50,312 $4.32 Million
Q3 2021

Nov 08, 2021

BUY
$73.77 - $83.61 $23,016 - $26,086
312 Added 0.63%
49,670 $4 Million
Q2 2021

Aug 12, 2021

SELL
$80.5 - $88.01 $49,668 - $54,302
-617 Reduced 1.23%
49,358 $3.97 Million
Q1 2021

May 07, 2021

SELL
$76.38 - $86.03 $99,752 - $112,355
-1,306 Reduced 2.55%
49,975 $4.22 Million
Q4 2020

Feb 09, 2021

SELL
$75.39 - $82.36 $547,934 - $598,592
-7,268 Reduced 12.41%
51,281 $4.12 Million
Q3 2020

Oct 29, 2020

BUY
$78.33 - $90.73 $31,175 - $36,110
398 Added 0.68%
58,549 $4.71 Million
Q2 2020

Aug 10, 2020

SELL
$78.66 - $94.14 $31,228 - $37,373
-397 Reduced 0.68%
58,151 $5.01 Million
Q1 2020

May 13, 2020

SELL
$71.57 - $93.3 $161,390 - $210,391
-2,255 Reduced 3.71%
58,548 $4.75 Million
Q4 2019

Feb 05, 2020

SELL
$76.7 - $88.45 $51,158 - $58,996
-667 Reduced 1.09%
60,803 $5.08 Million
Q3 2019

Nov 04, 2019

SELL
$81.4 - $89.78 $179,242 - $197,695
-2,202 Reduced 3.46%
61,470 $5.38 Million
Q2 2019

Aug 01, 2019

SELL
$73.44 - $82.41 $110,527 - $124,027
-1,505 Reduced 2.31%
63,672 $5.22 Million
Q1 2019

May 08, 2019

SELL
$64.48 - $81.31 $95,494 - $120,420
-1,481 Reduced 2.22%
65,177 $5.3 Million
Q4 2018

Jan 30, 2019

SELL
$61.45 - $77.8 $236,275 - $299,141
-3,845 Reduced 5.45%
66,658 $4.39 Million
Q3 2018

Nov 08, 2018

SELL
$70.71 - $77.75 $322,437 - $354,540
-4,560 Reduced 6.07%
70,503 $5.44 Million
Q2 2018

Aug 08, 2018

SELL
$63.43 - $75.41 $69,582 - $82,724
-1,097 Reduced 1.44%
75,063 $5.54 Million
Q1 2018

May 15, 2018

BUY
$62.56 - $72.26 $186,303 - $215,190
2,978 Added 4.07%
76,160 $4.95 Million
Q4 2017

Feb 08, 2018

SELL
$61.45 - $66.05 $644,241 - $692,468
-10,484 Reduced 12.53%
73,182 $4.73 Million
Q3 2017

Nov 02, 2017

SELL
$59.5 - $64.61 $65,093 - $70,683
-1,094 Reduced 1.29%
83,666 $5.25 Million
Q2 2017

May 14, 2018

SELL
N/A
-17,685 Reduced 17.26%
84,760 $5.13 Million
Q1 2017

May 14, 2018

SELL
N/A
-10,779 Reduced 9.52%
102,445 $5.31 Million
Q4 2016

May 14, 2018

BUY
N/A
113,224
113,224 $5.02 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Keybank National Association Portfolio

Follow Keybank National Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.